Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amgen melanoma drug improved survival by 21 pct in interim look
Amgen melanoma drug improved survival by 21 pct in interim look
Amgen melanoma drug improved survival by 21 pct in interim look
Submitted by
admin
on June 1, 2013 - 12:12pm
Source:
Reuters
News Tags:
Amgen
T-Vec
Talimogene Laherparepvec
melanoma
Headline:
Amgen melanoma drug improved survival by 21 pct in interim look
Do Not Allow Advertisers to Use My Personal information
